Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Guanabenz for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Phase 2a Study of HPG1860 in Subjects With NASH [Phase 2]
Phase 2a study update for HPG1860 in NASH (nonalcoholic steatohepatitis) is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2022-09-09Clinical Trial Update: A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis [Phase 2]
Phase 2 trial update of experimental medication BMS-986036 in adults with nonalcoholic steatohepatitis and stage 3 liver fibrosis; study com…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial studying miricorilant for nonalcoholic steatohepatitis (NASH) has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-11Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH [Phase 2]
Phase 2 trial evaluating ALS-L1023 for nonalcoholic steatohepatitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Companion Protocol for ¹³C-Methacetin Breath Tests in BMS: NCT03486899, NCT03486912 Referenced Trials
Completed clinical trial related to 13C-Methacetin breath tests in NASH (nonalcoholic steatohepatitis) with posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Study of Efruxifermin in Subjects With Histologically Confirmed Nonalcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 trial evaluating Efruxifermin for nonalcoholic steatohepatitis (NASH) has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-15Clinical Trial Update: A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects [Phase 2]
Phase 2 trial update for CRV431 in NASH patients with F2-F3 fibrosis; study completed and results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-05Clinical Trial Update: A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 clinical trial of seladelpar for nonalcoholic steatohepatitis (NASH) was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: FM101 Efficacy Study in Adults With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 clinical trial update for FM101 in adults with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
-
CLINICAL_TRIALS trial_result · 2022-06-14Clinical Trial Update: LIFT Study: A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of TERN-101 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study assessing safety, tolerability, efficacy, and pharmacokinetics of TERN-101 in non-cirrhotic non-alcoholic steatohepatitis (NAS…
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Clinical Trial to Investigate the Anti-oxidant Activity of Heptex in Patients With Apparent Risk Factors of NASH [Phase 2]
Phase 2 trial investigating the antioxidant activity of Heptex in patients with nonalcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver [Phase 4]
Phase 4 clinical trial examining the impact of an oral anti-diabetic medication on liver fat in adults with type 2 diabetes and non-alcoholi…
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis [Phase 1, Phase 2]
Clinical trial updates Montelukast for non-alcoholic steatohepatitis in Phase 1/2; the study is completed.
-
CLINICAL_TRIALS trial_result · 2022-03-10Clinical Trial Update: AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 3]
Phase 3 trial for cenicriviroc (CVC) in adults with nonalcoholic steatohepatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Safety, Tolerability, and Efficacy of Selonsertib, Firsocostat, and Cilofexor in Adults With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial assessing safety, tolerability, and efficacy of selonsertib, firsocostat, and cilofexor in adults with nonalcoholic steatohepa…
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis [Phase 2]
Phase 2 rollover study of cenicriviroc for liver fibrosis in nonalcoholic steatohepatitis was terminated; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: A Study of HTD1801 in Adults With Nonalcoholic Steatohepatitis (NASH) and Type 2 Diabetes Mellitus (T2DM) [Phase 2]
Phase 2 study of HTD1801 in adults with nonalcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (T2DM) completed; results posted in…
-
CLINICAL_TRIALS trial_result · 2021-11-16Clinical Trial Update: Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial assessing the efficacy and safety of elobixibat in combination with cholestyramine for nonalcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Comparing the Effects of Vitamin E, Ursodeoxycholic Acid and Pentoxyfylline on Egyptian Non-alcoholic Steatohepatitis (NASH) Patients [Phase 4]
Phase 4 trial comparing vitamin E, ursodeoxycholic acid, and pentoxifylline in Egyptian patients with nonalcoholic steatohepatitis (NASH) ha…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology [Phase 2]
Phase 2 clinical trial update for the HepQuant SHUNT test in monitoring liver disease (NASH) and treatment effects; study terminated with re…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 trial evaluating monotherapy and combination regimens for nonalcoholic steatohepatitis (NASH) completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH [Phase 3]
Phase 3 study update evaluating MSDC-0602K for glycemic control and cardiovascular outcomes in pre-diabetes/Type 2 diabetes with NAFLD/NASH;…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Biomarkers of Liver Pathology in Patients With Presumed Non-Alcoholic Steatohepatitis Following Bariatric Surgery [NA]
Clinical trial update studying biomarkers of liver pathology in patients with presumed non-alcoholic steatohepatitis after bariatric surgery…
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH [Phase 2]
Phase 2 trial evaluating MET409 alone or with empagliflozin in patients with type 2 diabetes and nonalcoholic steatohepatitis (NASH).